Apple Watch irregular heartbeat detection validated in 500,000-patient clinical study
The largest trial of wearable cardiac monitoring found the device identified previously undiagnosed atrial fibrillation in 2.1% of participants, prompting treatment in most cases.
4 min read
Tessa GreenHealth reporter
The largest trial of wearable cardiac monitoring found the device identified previously undiagnosed atrial fibrillation in 2.1% of participants, prompting treatment in most cases.
AT A GLANCE
- Editors are tracking this story through official briefings and local reporting.
- The newsroom will update this report as new verified detail becomes available.
The wider context matters as much as the headline. Our coverage separates confirmed facts from developing claims, explains the decisions behind the story, and highlights what readers should watch next.
The immediate impact is still being assessed, but the decisions now being made could shape policy, markets, and public trust well beyond the first news cycle.
